Cambridge, MA, United States of America

Biontech US Inc.


USPTO Granted Patents = 9


Trademarks = 6

Forward Citations = 5

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Michael Steven Rooney (4 out of 7 patents)

silverMedal Jennifer Grace Abelin (3 out of 3 patents)

bronzeMedal Dominik Barthelme (3 out of 3 patents)

4.  Vikram Juneja (3 out of 3 patents)

5.  Nir Hacohen (2 out of 27 patents)

6.  Divya Reddy Lenkala (2 out of 3 patents)

7.  Marit M Van Buuren (2 out of 3 patents)

8.  Jessica Kohler (2 out of 3 patents)

9.  Matthew Goldstein (2 out of 2 patents)

10.  Ed Fritsch (2 out of 2 patents)

11.  Renate De Boer (2 out of 3 patents)

12.  Ton Schumacher (2 out of 3 patents)

13.  Noor Bakker (2 out of 3 patents)

14.  Rob Carl Oslund (2 out of 2 patents)

15.  Robert Kamen (1 out of 3 patents)


9 patents:

Company Overview
Biontech US Inc. is a leading biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases. With a strong emphasis on research and development, the company works towards pioneering new treatment options that leverage cutting-edge technology and scientific expertise. Biontech US Inc. is dedicated to improving patient outcomes and transforming the way diseases are understood and treated.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#257 in Cambridge, MA

#1,926 in Massachusetts

#32,588 in US

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 5

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biontech US Inc.. Retrieved from https://idiyas.com/company/biontech-us

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…